摘要
目的·比较0.014 in的Synchro微导丝和Transend微导丝对急性缺血性脑卒中支架取栓的速度及安全性的影响。方法·入组2012年10月至2017年1月在上海交通大学医学院附属第九人民医院接受机械取栓的急性缺血性卒中患者46例,分为Synchro组(21例)和Transend组(25例),比较2组手术操作时间及安全性等指标。结果·2组闭塞血管再通率类似(P=0.600),但Synchro组从股动脉穿刺至血管再通时间显著短于Transend组(48.88 min vs 82.33 min,P=0.001)。2组患者术后3个月获得功能独立(mRS≤2)的比例类似(P=1.000),操作后蛛网膜下腔出血发生率类似(P=1.000)。但Transend组有2例因血管穿孔导致严重蛛网膜下腔出血伴血肿,均死亡;Synchro组仅有1例轻微的单纯蛛网膜下腔出血,恢复良好。结论·和Transend微导丝相比,Synchro微导丝能够缩短支架取栓操作时间,致命性蛛网膜下腔出血风险较小。
Objective · To compare the impacts on clinical efficiency and safety between 0.014 inch Synchro microwire and Transend microwire used during mechanical thrombectomy for acute ischemic stroke (AIS) caused by large artery occlusion. Methods · Forty-six patients undergoing mechanical thrombectomy with stent retrievers between October 2012 and January 2016 were included, who were classified into Synchro group (21 cases) and Transend group (25 cases). The clinical outcome, procedure time, and safety were analyzed and compared between two groups. Results · The recanalization rates were similar between two groups (P=0.600) , but time from puncture to vascular recanalization of Synchro group was much shorter than that of Transend goup (48.88 min vs 82.33 min, P=0.001). The rates of functional independence (modified Rankin scale score ≤ 2) were similar between two groups (P=1.000). There was no significant difference of the rates of post-procedure subarachnoid hemorrhage (PSAH) between two groups (P=1.000). However, there were two cases that had fatal subarachnoid hemorrhage with intracranial hematoma in Transend group, while there was only one case of mild subarachnoid hemorrhage who recovered well in Synchro group. Conclusion · Compared with Transend microwire, Synchro microwire can significantly shorten the procedure time of mechanical thrombectomy, and the risk of fatal subarachnoid hemorrhage is rather small.
出处
《上海交通大学学报(医学版)》
CSCD
北大核心
2017年第6期803-808,共6页
Journal of Shanghai Jiao tong University:Medical Science
基金
上海市教育委员会高峰高原学科建设计划(20161422)
上海交通大学医学院临床研究项目(DLY201614)
上海市"科技创新行动计划"生物医药领域科技支撑项目(16411953100)~~